A protocol for the diagnosis and treatment of extrapyramidal symptoms of neuroleptic drugs.
The incidence of extrapyramidal symptoms in persons taking neuroleptic medications is reported in a majority of patients and can be a contributing factor to non-compliance with prescribed regimens. This protocol was developed to assist the nurse practitioner in assessing and treating these symptoms as well as aiding in determining when to consult and/or refer a patient for further treatment and follow-up.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology; D009730:Nursing Assessment; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D014150:Antipsychotic Agents